Grail (GRAL) Net Margin (2023 - 2026)
Grail's (GRAL) quarterly Net Margin came in at 246.71% in Q2 2026, up 7398.0% on a YoY basis from 3.29% in Q2 2025, and down 7.98% quarter-over-quarter from 228.48% in Q1 2026.
Powered by 
Analysis
Grail (GRAL) Net Margin (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Net Margin for 4 consecutive years, with 246.71% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 7398.0% year-over-year to 246.71%; the trailing twelve-month figure through Jun 2026 stood at 249.09% (up 8077.0% YoY), and the FY2025 full-year result was 277.47%, up 133646.0% from the prior year.
- Net Margin eased to 246.71% in Q2 2026 per GRAL's latest filing, from 228.48% in the prior quarter.
- Across five years, Net Margin topped out at 202.57% in Q4 2023 and bottomed at 4958.83% in Q2 2024.
- Historically, Net Margin has averaged 1100.97% across 4 years, with a median of 327.15% in 2025.
- The sharpest annual moves came in 2024 and 2025: Net Margin sank 409756 bps in 2024, then surged 463814 bps in 2025.
- Over 4 years, Net Margin stood at 202.57% in 2023, then declined by 25 bps to 253.75% in 2024, then gained by 3 bps to 245.83% in 2025, then decreased by 0 bps to 246.71% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 246.71%, 228.48%, and 245.83% for Q2 2026, Q1 2026, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -8.89% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 10.65% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 8.02% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -35.87% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 2.22% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | -0.24% |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 16.69% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 7.36% |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -22.65% |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | -246.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -246.71% |
| Mar 31, 2026 | -228.48% |
| Sep 30, 2025 | -245.83% |
| Jun 30, 2025 | -320.69% |
| Mar 31, 2025 | -333.61% |
| Dec 31, 2024 | -253.75% |
| Sep 30, 2024 | -438.67% |
| Jun 30, 2024 | -4,958.83% |
| Mar 31, 2024 | -819.26% |
| Dec 31, 2023 | -202.57% |
| Oct 1, 2023 | -4,301.94% |
| Jun 30, 2023 | -861.27% |